The Magazine for Sleep Professionals
Thursday, October 22, 2026
We’re happy to announce that we’ve received our Phase I Small Business Innovation Research (SBIR) award from the National Institutes of Health, through the National Heart, Lung, and Blood Institute (NHLBI). This award supports real-world testing of our in-ear sensor system for in-lab and ambulatory sleep monitoring, along with the […]
CND Life Sciences announced the completion of growth financing led by S-Curve Partners, an operator-led healthcare investment firm focused on founder-inspired healthcare technology and diagnostics businesses. S-Curve was joined by current CND investors and shareholders, reflecting continued confidence in the Company’s commercial trajectory, expanding clinical adoption, and long-term strategic positioning. […]
On Wednesday morning, CND Life Sciences presented exciting new data at SLEEP 2026 from the NIH-sponsored Syn-Sleep Study, indicating that its Syn-One Test detected phosphorylated alpha-synuclein (P-SYN) in 75% of patients with idiopathic REM sleep behavior disorder (RBD). SleepWorld had a chance to sit down with CND Chief Medical Officer and […]
